Clinical Significance Of Molecular Response In Chronic Myeloid Leukemia (Cml) After Imatinib Mesylate (Gleevec) Therapy: Low Levels Of Residual Disease Predict For Response Duration.J Cortes,S O'Brien, M Talpaz,R Luthra, G Garcia-Manero, S Verstovsek, F Giles,Mb Rios, A Ferrajoli,W Wierda, D Thomas, S Faderl,H KantarjianBLOOD（2003）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
